JP Morgan Chase’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

JP Morgan Chase’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,500	Closed	-$15K	–	7115
2022 Q2	$15K	Sell	1,500 -250,000	-99%	-$2.47M	﹤0.01%	5961
2022 Q1	$2.48M	Buy	251,500 +250,000	+16,667%	+$2.46M	﹤0.01%	3592
2021 Q4	$15K	Sell	1,500 -248,500	-99%	-$2.45M	﹤0.01%	6274
2021 Q3	$2.45M	Hold	250,000	–	–	﹤0.01%	3621
2021 Q2	$2.47M	Buy	+250,000	New	+$2.52M	﹤0.01%	3640

Other funds holding LUXA

ECP

Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Wolfswood Holdings New York $2.84M AUM 30.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

JP Morgan Chase's LUXA Position: Q3 2022 in Review

JP Morgan Chase sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q3 2022, closing a stake of 1,500 shares — an estimated $15K sold.

JP Morgan Chase first reported a position in LUXA in Q2 2021 and held it in 5 quarters. The position peaked at $2.48M in Q1 2022. 72 funds tracked by Wall St. Rank hold LUXA as of Q3 2022.

JP Morgan Chase reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
JP Morgan Chase sold 1,500 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q3 2022, an estimated $15K.
JP Morgan Chase first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 5 quarters.
JP Morgan Chase's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $2.48M in Q1 2022.
72 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q3 2022.

Based on JP Morgan Chase's 13F filing for Q3 2022, filed 14 Nov 2022.